Catalyst Wire Dossier Catalyst Wire Dossier

LIFYORLI

RELACORILANT · Corcept Therapeutics Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LIFYORLI, covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: FDA Approved: LIFYORLI — Original Application (Corcept Therapeutics Incorporated)

See pricing